273 related articles for article (PubMed ID: 1282030)
1. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
[TBL] [Abstract][Full Text] [Related]
2. Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement.
Rother RP; Rollins SA; Mennone J; Chodera A; Fidel SA; Bessler M; Hillmen P; Squinto SP
Blood; 1994 Oct; 84(8):2604-11. PubMed ID: 7522635
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria.
Maciejewski JP; Young NS; Yu M; Anderson SM; Sloand EM
Thromb Res; 1996 Sep; 83(6):433-47. PubMed ID: 8885138
[TBL] [Abstract][Full Text] [Related]
5. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
6. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
Piedras J; López-Karpovitch X
Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
[TBL] [Abstract][Full Text] [Related]
8. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Nishimura Ji ; Phillips KL; Ware RE; Hall S; Wilson L; Gentry TL; Howard TA; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse WF; Smith CA
Blood; 2001 May; 97(10):3004-10. PubMed ID: 11342424
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a human T-cell line with deficient surface expression of glycosylphosphatidylinositol (GPI)-anchored proteins from a patient with paroxysmal nocturnal haemoglobinuria.
Masuda T; Yonemura Y; Fujimoto K; Hidaka M; Nagakura S; Nakakuma H; Hata H; Sanada I; Kawakita M; Takatsuki K
Br J Haematol; 1994 May; 87(1):24-30. PubMed ID: 7524616
[TBL] [Abstract][Full Text] [Related]
10. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
Shichishima T
Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
[TBL] [Abstract][Full Text] [Related]
11. Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor.
Kinoshita T
Semin Hematol; 2018 Jul; 55(3):136-140. PubMed ID: 30032750
[TBL] [Abstract][Full Text] [Related]
12. Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype.
Hillmen P; Bessler M; Crawford DH; Luzzatto L
Blood; 1993 Jan; 81(1):193-9. PubMed ID: 7678064
[TBL] [Abstract][Full Text] [Related]
13. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
Edberg JC; Salmon JE; Whitlow M; Kimberly RP
J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
[TBL] [Abstract][Full Text] [Related]
14. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
Ninomiya H; Kobayashi T; Abe T
Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
[TBL] [Abstract][Full Text] [Related]
15. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
Nishimura J; Murakami Y; Kinoshita T
Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
[TBL] [Abstract][Full Text] [Related]
16. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria.
Terstappen LW; Nguyen M; Huang S; Lazarus HM; Medof ME
Br J Haematol; 1993 Jul; 84(3):504-14. PubMed ID: 7692931
[TBL] [Abstract][Full Text] [Related]
17. The PIG-anchoring defect in NK lymphocytes of PNH patients.
Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
[TBL] [Abstract][Full Text] [Related]
18. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
Telen MJ
Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2-dependent T-cell lines established from paroxysmal nocturnal hemoglobinuria patients.
Nakakuma H; Nagakura S; Horikawa K; Hidaka M; Kawaguchi T; Iwamoto N; Sanada I; Kagimoto T; Takatsuki K
Blood; 1994 Jul; 84(1):309-14. PubMed ID: 7517213
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and diagnosis of paroxysmal nocturnal hemoglobinuria: correlates with the deficiency of GPI-anchored membrane proteins].
Ninomiya H
Rinsho Ketsueki; 1994 Apr; 35(4):352-7. PubMed ID: 7518013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]